Education
About Us
Working with TipRanks
Follow Us
Elixinol Wellness (ELLXF)
OTHER OTC:ELLXF
ELLXF Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.04
Previous CloseN/A
Volume25.00
Average Volume (3M)5.17K
Market Cap
$2.91M
Enterprise Value$4.19M
Total Cash (Recent Filing)$1.09M
Total Debt (Recent Filing)$3.10M
Price to Earnings (P/E)―
Beta-3.14
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding413,987,730
10 Day Avg. Volume617
30 Day Avg. Volume5,165
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)0.59
Price to Sales (P/S)0.39
P/FCF Ratio-1.66
Enterprise Value/Market Cap1.44
Enterprise Value/Revenue0.26
Enterprise Value/Gross Profit0.75
Enterprise Value/Ebitda-0.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Robust Revenue GrowthSustained revenue expansion approaching +80% YoY signals meaningful demand for the company’s hemp wellness offerings and validates go-to-market channels. Durable top-line momentum provides room to scale gross margins and amortize fixed costs if cost controls and unit economics improve.
Conservative LeverageA low debt-to-equity ratio indicates modest financial leverage, preserving balance sheet flexibility to fund growth or weather regulatory volatility in the hemp sector. This reduces refinancing risk and supports strategic investments without large interest burdens over the medium term.
Multi-channel Revenue ModelA mix of DTC and wholesale distribution diversifies revenue exposure and customer acquisition pathways. This structural channel flexibility can lower customer concentration risk, enable higher lifetime value via DTC, and support scale through wholesale distribution over several quarters.
Bears Say
Ongoing UnprofitabilityPersistent negative EBIT and net income margins indicate core operations are not yet self-sustaining. Without durable margin improvement or material gross-margin expansion, continued losses will erode equity and require ongoing external financing, constraining long-term shareholder returns.
Negative Operating And Free Cash FlowNegative operating and free cash flow mean the business does not generate internal funding for growth or working capital. Reliance on financing increases execution risk and raises the need to improve working-capital management and convert revenue growth into sustainable cash generation.
Weakened Equity RatioA declining equity ratio signals balance-sheet erosion that can limit strategic flexibility and borrowing capacity. Over months this reduction raises vulnerability to shocks, increases the importance of restoring retained earnings via profitability or equity raises to maintain financial resilience.
Elixinol Wellness News
ELLXF FAQ
What was Elixinol Wellness’s price range in the past 12 months?
Elixinol Wellness lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
What is Elixinol Wellness’s market cap?
Elixinol Wellness’s market cap is $2.91M.
When is Elixinol Wellness’s upcoming earnings report date?
Elixinol Wellness’s upcoming earnings report date is Mar 04, 2026 which is in 28 days.
How were Elixinol Wellness’s earnings last quarter?
Elixinol Wellness released its earnings results on Aug 29, 2025. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Elixinol Wellness overvalued?
According to Wall Street analysts Elixinol Wellness’s price is currently Overvalued.
Does Elixinol Wellness pay dividends?
Elixinol Wellness does not currently pay dividends.
What is Elixinol Wellness’s EPS estimate?
Elixinol Wellness’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elixinol Wellness have?
Elixinol Wellness has 413,987,730 shares outstanding.
What happened to Elixinol Wellness’s price movement after its last earnings report?
Elixinol Wellness reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 30%.
Which hedge fund is a major shareholder of Elixinol Wellness?
Currently, no hedge funds are holding shares in ELLXF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elixinol Wellness Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-26.84%
Trailing 12-Months
Asset Growth
32.98%
Trailing 12-Months
Company Description
Elixinol Wellness
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---